Muscle spasticity, a common symptom of multiple sclerosis (MS), can make everyday movements feel stiff, tight, and painful. Stretching is one way to help reduce some of that discomfort, improve ...

There is now conclusive and reassuring evidence of the cannnabis-based treatment Sativex’s tolerability and effectiveness in reducing spasticity and related symptoms in multiple sclerosis, according ...

Arbaclofen extended-release tablets were found to be a safe treatment that reduced spasticity in patients with multiple sclerosis. Arbaclofen extended-release (ER) reduced spasticity in patients with ...

Investigators sought to determine the safety and efficacy of twice-daily dosing of arbaclofen ER in patients with spasticity due to multiple sclerosis. SEATTLE – Twice-daily arbaclofen ...

February 11, 2011 — In patients with severe spasticity related to multiple sclerosis (MS), intrathecal baclofen (ITB) using a programmable, subcutaneously implanted pump can be an effective ...

People with multiple sclerosis have long said that smoking marijuana helps ease their painful muscle cramping. And a new clinical trial suggests they are not just blowing smoke. The study, published ...

May 24, 2012 — Spasticity is a common and disabling problem for many patients with multiple sclerosis (MS). A new study shows that smoking marijuana can relieve muscle spasms and pain in patients with ...

June 28 -- FRIDAY, June 27 (HealthDay News) -- People with multiple sclerosis are at a greater risk than the general population for developing restless legs syndrome (RLS), a new Italian study ...

A new study found smoking cannabis reduced spasticity in MS patients. May 14, 2012— -- Smoking marijuana may reduce certain symptoms in patients with multiple sclerosis, according to a new small ...

A new study suggests patients with multiple sclerosis (MS) will see their ability to walk decline more rapidly than their hand function. A new analysis of disease progression in patients with multiple ...

Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity ...